Form 8-K - Current report:
SEC Accession No. 0001140361-22-009871
Filing Date
2022-03-17
Accepted
2022-03-17 09:36:43
Documents
14
Period of Report
2022-03-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20003153x5_8k.htm   iXBRL 8-K 28179
2 EXHIBIT 3.1 ny20003153x5_ex3-1.htm EX-3.1 1180
6 ny20003153x5_ex3-1img01.jpg GRAPHIC 966712
  Complete submission text file 0001140361-22-009871.txt   1421750

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20220314.xsd EX-101.SCH 3917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220314_lab.xml EX-101.LAB 23289
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220314_pre.xml EX-101.PRE 16546
8 EXTRACTED XBRL INSTANCE DOCUMENT ny20003153x5_8k_htm.xml XML 4213
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 22746994
SIC: 2835 In Vitro & In Vivo Diagnostic Substances